Metaplastic Breast Carcinoma: A Case Series with Three Different Presentations

Metaplastic Breast Carcinoma (MBC) is one among the rare types of breast carcinoma. MBC was recognised as a separate entity by World Health Organisation (WHO) in 2020. According to WHO, metaplastic carcinoma is classified into six types based on the histology which includes: low grade adenosquamous...

Full description

Bibliographic Details
Main Authors: Binia Sherin, Evelyn Angel
Format: Article
Language:English
Published: JCDR Research and Publications Pvt. Ltd. 2023-01-01
Series:National Journal of Laboratory Medicine
Subjects:
Online Access:https://njlm.net/article_FULLTEXT.aspx?issn=0973-709x&year=2023&month=January&volume=12&issue=1&page=PS01%20-%20PS04&id=2702
_version_ 1797946813182902272
author Binia Sherin
Evelyn Angel
author_facet Binia Sherin
Evelyn Angel
author_sort Binia Sherin
collection DOAJ
description Metaplastic Breast Carcinoma (MBC) is one among the rare types of breast carcinoma. MBC was recognised as a separate entity by World Health Organisation (WHO) in 2020. According to WHO, metaplastic carcinoma is classified into six types based on the histology which includes: low grade adenosquamous carcinoma; fibromatosis like metaplastic carcinoma; squamous cell carcinoma; spindle cell carcinoma; carcinoma with heterologous mesenchymal differentiation; and mixed metaplastic carcinomas. This rare type of tumour shows both epithelial and/or mesenchymal elements within the same lesion. The management of these patients remains an enigma due to the rarity of the tumour and the treatment responses between patients following therapy. In the present case series, five cases of MBC and their follow-up have been described. All patients were females within the age group of 50-65 years. All five patients underwent modified radical mastectomy. Lymph node involvement was noted in one case. Among the five cases, two patients had adenosquamous carcinoma, two patients had metaplastic carcinoma with heterologous mesenchymal differentiation and one patient had mixed metaplastic carcinoma.
first_indexed 2024-04-10T21:16:58Z
format Article
id doaj.art-f52436a5348043908fbfd1e108a7c117
institution Directory Open Access Journal
issn 2277-8551
2455-6882
language English
last_indexed 2024-04-10T21:16:58Z
publishDate 2023-01-01
publisher JCDR Research and Publications Pvt. Ltd.
record_format Article
series National Journal of Laboratory Medicine
spelling doaj.art-f52436a5348043908fbfd1e108a7c1172023-01-20T11:43:57ZengJCDR Research and Publications Pvt. Ltd.National Journal of Laboratory Medicine2277-85512455-68822023-01-01121PS01PS0410.7860/NJLM/2023/59185.2702Metaplastic Breast Carcinoma: A Case Series with Three Different PresentationsBinia Sherin0Evelyn Angel1Assistant Professor, Department of Pathology, Sree Mookambika Institute of Medical Sciences, Nagerkoil, Tamil Nadu, India. Associate Professor, Department of Pathology, Sree Mookambika Institute of Medical Sciences, Nagerkoil, Tamil Nadu, India. Metaplastic Breast Carcinoma (MBC) is one among the rare types of breast carcinoma. MBC was recognised as a separate entity by World Health Organisation (WHO) in 2020. According to WHO, metaplastic carcinoma is classified into six types based on the histology which includes: low grade adenosquamous carcinoma; fibromatosis like metaplastic carcinoma; squamous cell carcinoma; spindle cell carcinoma; carcinoma with heterologous mesenchymal differentiation; and mixed metaplastic carcinomas. This rare type of tumour shows both epithelial and/or mesenchymal elements within the same lesion. The management of these patients remains an enigma due to the rarity of the tumour and the treatment responses between patients following therapy. In the present case series, five cases of MBC and their follow-up have been described. All patients were females within the age group of 50-65 years. All five patients underwent modified radical mastectomy. Lymph node involvement was noted in one case. Among the five cases, two patients had adenosquamous carcinoma, two patients had metaplastic carcinoma with heterologous mesenchymal differentiation and one patient had mixed metaplastic carcinoma.https://njlm.net/article_FULLTEXT.aspx?issn=0973-709x&year=2023&month=January&volume=12&issue=1&page=PS01%20-%20PS04&id=2702adenosquamous carcinomaprognosistriple negative breast carcinoma
spellingShingle Binia Sherin
Evelyn Angel
Metaplastic Breast Carcinoma: A Case Series with Three Different Presentations
National Journal of Laboratory Medicine
adenosquamous carcinoma
prognosis
triple negative breast carcinoma
title Metaplastic Breast Carcinoma: A Case Series with Three Different Presentations
title_full Metaplastic Breast Carcinoma: A Case Series with Three Different Presentations
title_fullStr Metaplastic Breast Carcinoma: A Case Series with Three Different Presentations
title_full_unstemmed Metaplastic Breast Carcinoma: A Case Series with Three Different Presentations
title_short Metaplastic Breast Carcinoma: A Case Series with Three Different Presentations
title_sort metaplastic breast carcinoma a case series with three different presentations
topic adenosquamous carcinoma
prognosis
triple negative breast carcinoma
url https://njlm.net/article_FULLTEXT.aspx?issn=0973-709x&year=2023&month=January&volume=12&issue=1&page=PS01%20-%20PS04&id=2702
work_keys_str_mv AT biniasherin metaplasticbreastcarcinomaacaseserieswiththreedifferentpresentations
AT evelynangel metaplasticbreastcarcinomaacaseserieswiththreedifferentpresentations